ArticleACR open rheumatology2025

Safety of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Combined Data From Three Clinical Trials.

Peter A Merkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.